• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More or Call (407) 374-6986

Thursday 11/15/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

hemorrhoids

  • 4:42 PM

    CRANFORD, N.J., Aug. 23, 2016 /PRNewswire/ — Citius Pharmaceuticals, Inc. (“Citius”) (OTC BB: CTXR), a specialty pharmaceutical company dedicated to developing and commercializing adjunctive cancer care and critical care drug products, announced completion of market research with in-depth interviews on patient-reported signs and symptoms of hemorrhoids and treatment outcomes with its Hydro-Lido product. Citius and the market research group conducted in-depth, in-person and telephonic interviews of patients who were diagnosed with grade II and grade III hemorrhoid disease. The interviews

    Read more
  • 5:28 PM

    IRVINE, Calif., Sep 05, 2014 (GLOBE NEWSWIRE via COMTEX) — Universal Bioenergy Inc., (OTCPINK:UBRG), a publicly traded diversified energy company that markets and distributes natural gas, petroleum, coal and electricity, announced that its subsidiary NDR Energy Group signed an agreement to supply natural gas to one of the top five largest electric and gas power companies in America. The agreement is projected to generate tens of millions of dollars in additional revenue for the Company from the sales of natural

    Read more
Public Wire Banner